Corpechot et al refined criteria for a biochemical response to therapy with ursodeoxcholic acid (UDCA) in a patient with primary biliary cirrhosis (PBC). The authors are from Hoital Saint-Antoine Publique-Hopitaux de Paris and Universite Pierre et Marie Curie in Paris.